Zura Bio ZURA
NASDAQ ZURA
$4.11 -0.03 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zura Bio (ZURA) Preferred Stock Liabilities (2021 - 2022)

Updated

Zura Bio (ZURA) recorded Preferred Stock Liabilities of $12.5 million in Q4 2022, down 91.0% from $139.38 million a year earlier and down 91.1% from the prior quarter.

Analysis

Zura Bio (ZURA) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends

Starting with Q4 2021, Zura Bio's Preferred Stock Liabilities history includes 5 quarters.

  • Across earlier years, Preferred Stock Liabilities came in at $139.38 million in FY2021.
  • Per Business Quant, the preceding three quarters came in at $140.18 million (Q3 2022), $139.5 million (Q2 2022) and $139.38 million (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Zura Bio 521.16 Mn 521.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 12.50 Mn
Sep 30, 2022 140.18 Mn
Jun 30, 2022 139.50 Mn
Mar 31, 2022 139.38 Mn
Dec 31, 2021 139.38 Mn
API Access

Zura Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ZURA&period=max&api_key=YOUR_API_KEY